This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Charlotte-Hanneman, CFO at Philips What You Should Know: – Philips (NYSE: PHG, AEX: PHIA), a global leader in healthtechnology, has announced the appointment of Charlotte Hanneman as its new Chief Financial Officer (CFO). Hanneman brings over 20 years of experience in the MedTech and pharmaceutical industries. – Ms.
That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.
That a pharmaceutical company executive is speaking on the main stage at CES speaks to the category’s mainstreaming beyond elite athletes and smartwatches that track activity. As Ford is quoted in the CES 2022 press release, “CES is the ideal stage to spotlight how technology is allowing people to take control of their health.
Dose shortages elevated the role of pharmaceutical executives. The answer to one of the most important public health questions of our time — who gets access to vaccines? The answer to one of the most important public health questions of our time — who gets access to vaccines? — Private decisions did not match public health need.
For over ten years, digital healthtechnology has been a fast-growing area at the annual CES , the largest convention covering consumer electronics in the world. The company is offering a hearing device integrating deep neural network technology that offers “BrainHearing through the ear” in a customized hearing aid.
Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medicaltechnologies, particularly in Eastern Europe and developing countries.
Activists anticipated the rise of vaccine, therapeutic, and testing nationalism — with rich countries securing preferential access to COVID-19 medicaltechnologies and preventing export to other countries even before they had been approved — and the press soon followed.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content